Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads In Liver Disease

Liver Disease for January/February 2020

GALAD score predicts NASH-HCC more than a year in advance,

Long-term entecavir looks safe, effective in HBV,

More must reads

Liver Disease for November/December 2019

Fibrosis scoring systems have ‘modest’ predictive value in general population,

No clear-cut evidence of vedolizumab effect in retrospective study of primary sclerosing cholangitis,

Blocking TLR9 may halt brain edema in acute liver failure,

More must reads

Liver Disease for May/June 2019

Palliative Care Has Multiple Barriers in End-Stage Liver Disease,

More must reads

Liver Disease for March/April 2019

Tailoring the Mediterranean diet for NAFLD,

MicroRNA-375 May Be Therapeutic Strategy in Fibrolamellar Carcinoma,

Biomarkers of Regorafenib Response in Hepatocellular Carcinoma,

High-Calorie Diet May Worsen Wilson Disease,

Women Survive More Often Than Men When Hospitalized with Cirrhosis,

More must reads

Liver Disease for November/December 2018

Risk of Advanced Liver Disease in Hispanics , Clin Gastroenterol Hepatol; ePub 2018 Dec 7; Turner, et al
More must reads

Pages